000 00958 a2200265 4500
005 20250515234555.0
264 0 _c20110125
008 201101s 0 0 ger d
022 _a1435-1250
024 7 _a10.1007/s00393-009-0533-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlten, R
245 0 0 _a[Selective co-stimulation blockade. CTLA4-Ig (Abatacept)].
_h[electronic resource]
260 _bZeitschrift fur Rheumatologie
_cSep 2010
300 _a601-7 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article
650 0 4 _aAbatacept
650 0 4 _aAntirheumatic Agents
_xtherapeutic use
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImmunoconjugates
_xtherapeutic use
700 1 _aMärker-Hermann, E
773 0 _tZeitschrift fur Rheumatologie
_gvol. 69
_gno. 7
_gp. 601-7
856 4 0 _uhttps://doi.org/10.1007/s00393-009-0533-4
_zAvailable from publisher's website
999 _c20041065
_d20041065